In what circumstance might a nurse question a provider's order for a lipid-lowering agent?

In what circumstance might a nurse question a provider's order for a lipid-lowering agent?

• A. When the client reports occasional muscle cramps
• B. When the client has a history of liver disease
• C. When the client is on a high-fiber diet
• D. When the client has started a new exercise program

Answer: (B)

Questioning a provider's order for a lipid-lowering agent, particularly in the context of a client with a history of liver disease, is critical due to the potential for significant adverse effects on liver function associated with these medications. Many lipid-lowering agents, specifically statins, can cause hepatotoxicity or exacerbate existing liver conditions. This necessitates caution and, in many cases, the avoidance of these agents in individuals with liver disease. Monitoring liver enzymes is often a standard protocol before initiating therapy with statins and at intervals thereafter; however, if a client already has a compromised liver, the risks may outweigh the benefits of starting such treatment. Thus, the nurse must advocate for the patient by questioning the appropriateness of the therapy in light of the patient's medical history, ensuring that patient safety is prioritized. In contrast, occasional muscle cramps, a high-fiber diet, or starting a new exercise program do not inherently suggest contraindications for initiating lipid-lowering therapy. Such factors may warrant discussion or monitoring but do not typically raise immediate concerns that would prompt questioning of the prescription itself.

Questioning a provider's order for a lipid-lowering agent, particularly in the context of a client with a history of liver disease, is critical due to the potential for significant adverse effects on liver function associated with these medications. Many lipid-lowering agents, specifically statins, can cause hepatotoxicity or exacerbate existing liver conditions. This necessitates caution and, in many cases, the avoidance of these agents in individuals with liver disease.

Monitoring liver enzymes is often a standard protocol before initiating therapy with statins and at intervals thereafter; however, if a client already has a compromised liver, the risks may outweigh the benefits of starting such treatment. Thus, the nurse must advocate for the patient by questioning the appropriateness of the therapy in light of the patient's medical history, ensuring that patient safety is prioritized.

In contrast, occasional muscle cramps, a high-fiber diet, or starting a new exercise program do not inherently suggest contraindications for initiating lipid-lowering therapy. Such factors may warrant discussion or monitoring but do not typically raise immediate concerns that would prompt questioning of the prescription itself.